Cullinan Therapeutics (CGEM) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | 64.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.35 Mn |
| Mar 31, 2026 | 61.45 Mn |
| Dec 31, 2025 | 60.24 Mn |
| Sep 30, 2025 | 59.08 Mn |
| Jun 30, 2025 | 59.07 Mn |
| Mar 31, 2025 | 58.70 Mn |
| Dec 31, 2024 | 58.51 Mn |
| Sep 30, 2024 | 58.14 Mn |
| Jun 30, 2024 | 57.87 Mn |
| Mar 31, 2024 | 43.07 Mn |
| Dec 31, 2023 | 42.90 Mn |
| Sep 30, 2023 | 42.76 Mn |
| Jun 30, 2023 | 42.74 Mn |
| Mar 31, 2023 | 39.34 Mn |
| Dec 31, 2022 | 45.80 Mn |
| Sep 30, 2022 | 45.74 Mn |
| Jun 30, 2022 | 45.40 Mn |
| Mar 31, 2022 | 44.66 Mn |
| Dec 31, 2021 | 44.29 Mn |
| Sep 30, 2021 | 43.66 Mn |